#USA #Boston #Embr Labs #POTS #Embr Wave

Embr Labs Announces Major Milestones in Digital Thermal Health

Embr Labs, a pioneering company in digital thermal health technology, has recently made significant advancements that affirm its position as a leader in wearable thermal solutions. The Boston-based firm has achieved clinical validation from Stanford University, expanded its intellectual property in Japan, and launched an open-source research API and SDK for its renowned Embr Wave 2 device.

Clinical Validation for Enhanced Quality of Life

One of the groundbreaking developments comes from a pilot study conducted by Dr. Mitchell Miglis at Stanford University. The study, recently featured in Autonomic Neuroscience Basic and Clinical, highlights the immense benefits of the Embr Wave™ wearable for individuals suffering from Postural Tachycardia Syndrome (POTS). POTS patients often face debilitating temperature intolerance, which has historically been overlooked in treatment plans.

The pilot study, conducted over a 28-day period with 22 participants, has shown statistically significant improvements in quality of life. Dr. Miglis noted, “Most patients with POTS report temperature intolerance, which can be quite debilitating and significantly limit their quality of life. Our study found both immediate and sustained reductions in various temperature intolerance-related quality of life domains.” Notably, the percentage of patients reporting moderate-to-severe limitations on leisure activities dropped from 45% to 0%. This momentous finding underscores the potential of the Embr Wave to enhance the daily experiences of patients suffering from this condition.

Expansion of Intellectual Property in Japan

Further cementing its innovative status, Embr Labs has secured two foundational patents in Japan for the Embr Wave 2. These patents protect the unique delivery of physiologically optimized thermal waves and introduce a “Track and Learn” feature, which helps users create personalized usage logs. This functionality is designed to assist users in understanding their thermal patterns better, thereby enhancing the therapeutic use of the product.

Open-Source Initiative for Global Research

In a bold move to foster innovation in thermal solutions, Embr Labs has launched a public open-source API and SDK. This allows the scientific community to integrate the Embr Wave 2 into their research more effectively. Researchers can now control thermal stimuli with precise timing, using either existing software or developing custom solutions tailored to their experiments. Matt Smith, Co-Founder and CTO of Embr Labs, remarked, “We receive regular requests from researchers worldwide to incorporate Embr Wave 2 into their studies. We are thrilled to support the ongoing exploration of how thermal sensations can enhance human experiences.”

About Embr Labs

Founded at the prestigious Massachusetts Institute of Technology (MIT), Embr Labs has consistently been recognized for its innovative health technology solutions. The company is dedicated to addressing various health issues related to temperature, from hot flashes to sleep disturbances. Embr Labs has earned numerous accolades, including the AARP Innovation in Aging Award and Time Magazine's Best Inventions recognition.

In conclusion, Embr Labs is not merely leading the market but is setting the stage for a new era in healthtech, harnessing the power of temperature to improve lives. With continuing clinical studies, robust patent protections, and an expansive open-source platform, the company stands at the forefront of innovation in digital thermal health solutions. As they pave the way forward, the future of thermal health technology looks brighter than ever.